BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37140088)

  • 21. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer in transgender women: what does a urologist need to know?
    Bertoncelli Tanaka M; Sahota K; Burn J; Falconer A; Winkler M; Ahmed HU; Rashid TG;
    BJU Int; 2022 Jan; 129(1):113-122. PubMed ID: 34157213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
    Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
    J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonprescription Hormone Use Among Transgender Women - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
    Olansky E; Lee K; Handanagic S; Trujillo L; ;
    MMWR Suppl; 2024 Jan; 73(1):34-39. PubMed ID: 38261588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
    Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
    JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncovering the effects of gender affirming hormone therapy on skeletal muscle and epigenetics: protocol for a prospective matched cohort study in transgender individuals (the GAME study).
    Jones PR; Voisin S; Nolan BJ; Landen S; Jacques M; Newell B; Zwickl S; Cook T; Wong A; Ginger A; Palmer A; Garnham A; Alvarez-Romero J; Mohandas N; Seale K; Cheung A; Eynon N
    BMJ Open; 2022 May; 12(5):e060869. PubMed ID: 35545400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
    Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
    J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
    Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
    JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of cancer in children and young adults conceived by assisted reproductive technology.
    Spaan M; van den Belt-Dusebout AW; van den Heuvel-Eibrink MM; Hauptmann M; Lambalk CB; Burger CW; van Leeuwen FE;
    Hum Reprod; 2019 Apr; 34(4):740-750. PubMed ID: 30715305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.
    Rutnin S; Suchonwanit P; Kositkuljorn C; Pomsoong C; Korpaisarn S; Arunakul J; Rattananukrom T
    Transgend Health; 2023 Feb; 8(1):89-99. PubMed ID: 36824384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There a Link Between Hormone Use and Diabetes Incidence in Transgender People? Data From the STRONG Cohort.
    Islam N; Nash R; Zhang Q; Panagiotakopoulos L; Daley T; Bhasin S; Getahun D; Sonya Haw J; McCracken C; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1549-e1557. PubMed ID: 34850912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility, Contraception, and Fertility Preservation in Trans Individuals.
    Feil K; Reiser E; Braun AS; Böttcher B; Toth B
    Dtsch Arztebl Int; 2023 Apr; 120(14):243-250. PubMed ID: 36794399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.